Med-Chemist : "Quintessential Medicinal Chemistry"
Monday, September 12, 2011
In continuation of my updates on
Rivaroxaban
...
FDA Issues Complete Response Letter to Johnson & Johnson Pharmaceutical Research & Development Regarding New Drug Application for Tapentadol Extended Release....
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment